Bitter Melon (Momordica charantia)

Momordica charantia
Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Bitter melon (also called bitter gourd, karela) is a tropical vine fruit used as both food and medicine across South Asia, Africa, and the Caribbean. Used for diabetes for centuries. Active compounds include charantin, vicine, polypeptide-p ('plant insulin'), and momordicin. Modest evidence for glycemic improvement in T2DM. CRITICAL CAUTION: contains potential teratogens — AVOID during pregnancy. Vicine causes favism in G6PD-deficient individuals.

Studied Dose 1-3 g/day fruit/seed powder; 200-500 mg/day standardized extract; juice 50-100 mL/day
Active Compound Charantin (cucurbitane-type triterpenoids), polypeptide-p ('plant insulin'), vicine, momordicin

Benefits

T2DM Glycemic Modest Improvement

Multiple trials (especially Cefalu 2008, Fuangchan 2011) show bitter melon modestly reduces fasting glucose and HbA1c in T2DM patients. Effect generally smaller than metformin. Evidence varies by formulation, dose, duration.

Insulin-Like Effects ('Plant Insulin')

Polypeptide-p has structural similarity to insulin and was historically called 'plant insulin' or 'p-insulin' — modest insulin-mimetic activity. Mechanism interesting but clinical effect modest.

Anti-Inflammatory and Antioxidant

Multiple bitter melon compounds have antioxidant and anti-inflammatory effects in vitro. Modest contribution to overall metabolic benefit.

Cholesterol Modest Reduction

Some trials show modest cholesterol and triglyceride reduction. Less consistent than glycemic effects.

Weight Management Adjunct

Modest effects on weight and visceral fat in some trials. Substantially smaller effect than evidence-based weight management interventions.

Mechanism of action

1

Insulin Receptor Activation

Polypeptide-p and other bitter melon compounds activate insulin receptor signaling — modestly mimicking insulin. Mechanistically interesting.

2

AMPK Activation

Bitter melon activates AMP-activated protein kinase (AMPK) — same target as metformin and exercise. Improves glucose uptake and reduces gluconeogenesis.

3

Alpha-Glucosidase Inhibition

Bitter melon compounds inhibit alpha-glucosidase — reducing carbohydrate digestion and post-prandial glucose. Similar mechanism to acarbose.

4

Charantin Triterpenoid Effects

Charantin (cucurbitane-type triterpenoids) modulates multiple pathways including PPAR-gamma — similar mechanism to thiazolidinedione drugs (pioglitazone). Improves insulin sensitivity.

Clinical trials

1
Bitter Melon for T2DM

Clinical trial comparing bitter melon (500 mg or 1,000 mg or 2,000 mg/day) vs metformin (1,000 mg/day) in 143 T2DM patients for 4 weeks.

143 T2DM patients.

Bitter melon 2,000 mg/day modestly reduced fructosamine and glucose; effect smaller than metformin. Lower doses showed minimal effect. Established modest dose-dependent glycemic effect.

2
Bitter Melon Cochrane Review (Negative)

Cochrane evidence review of bitter melon for T2DM.

Pooled across T2DM clinical trials.

Insufficient evidence to recommend bitter melon for T2DM; effects modest and inconsistent across trials. Standard T2DM management primary.

Side effects and drug interactions

Common Potential side effects

GI distress (nausea, abdominal pain, diarrhea) — particularly with juice forms.
Hypoglycemia with insulin/sulfonylureas.
FAVISM in G6PD-DEFICIENT individuals — bitter melon SEEDS contain VICINE (same compound as fava beans) that causes hemolytic anemia in G6PD-deficient people; AVOID seeds in this population.
Headache.
BITTER TASTE — major palatability issue with juice/whole fruit.
POTENTIAL TERATOGEN — animal studies suggest abortifacient and teratogenic effects; AVOID in pregnancy.
Liver enzyme elevation (rare).

Important Drug interactions

Insulin / sulfonylureas — additive hypoglycemic; monitor closely.
Metformin — generally compatible; modest additive effects.
GLP-1 agonists, SGLT2 inhibitors — modest additive.
Anticoagulants — theoretical bleeding risk at high doses.
Drugs metabolized by CYP enzymes — bitter melon may modestly affect; theoretical interactions.

Frequently asked questions about Bitter Melon (Momordica charantia)

What is bitter melon used for?

Bitter melon is a tropical vegetable used, especially in Asian traditions, for blood-sugar support. It contains compounds with insulin-like and glucose-lowering activity, and is eaten as a food or taken as juice or extract.

Does bitter melon help with blood sugar?

Bitter melon is traditionally and in some studies used to support healthy blood sugar, with several compounds that may improve glucose uptake. Evidence is mixed and effects modest, so it is supportive rather than a treatment.

How much bitter melon should I take?

It is eaten as a vegetable, drunk as juice, or taken as a standardized extract; follow product labeling. It is intensely bitter, hence the name. Take it with meals for blood-sugar goals.

Is bitter melon safe?

As a food it is safe. As a concentrated supplement it can lower blood sugar, so those on diabetes medication should monitor and check with a doctor. Pregnant women should avoid medicinal amounts, as it has traditional reproductive cautions.

What is Bitter Melon (Momordica charantia)?

Bitter melon (also called bitter gourd, karela) is a tropical vine fruit used as both food and medicine across South Asia, Africa, and the Caribbean. Used for diabetes for centuries. Active compounds include charantin, vicine, polypeptide-p ('plant insulin'), and momordicin.